Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Alabama at Birmingham
Travera Inc
Centre Oscar Lambret
NeoImmuneTech
M.D. Anderson Cancer Center
Pheon Therapeutics
iOMEDICO AG
DualityBio Inc.
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Tanabe Pharma America, Inc.
CRISPR Therapeutics
TScan Therapeutics, Inc.
Massive Bio, Inc.
Weill Medical College of Cornell University
Nuvectis Pharma, Inc.
CNAO National Center of Oncological Hadrontherapy
GlaxoSmithKline
Marengo Therapeutics, Inc.
Numab Therapeutics AG
Laval University
Laval University
Stanford University
Centre Hospitalier Universitaire de Nīmes
Tampere University Hospital
Grupo Español de Investigación en Cáncer de Ovario
University of California, San Diego
Travera Inc
Cancer Research UK
Elucida Oncology
The First Affiliated Hospital with Nanjing Medical University
Advaxis, Inc.
Eisai Inc.
Fujian Cancer Hospital
Evopoint Biosciences Inc.
Centre Leon Berard
Catalysis SL
Celon Pharma SA
Myeloid Therapeutics
Charite University, Berlin, Germany
Multitude Therapeutics Inc.
Kineta Inc.
Queensland Centre for Gynaecological Cancer
Instituto do Cancer do Estado de São Paulo
Chang Gung Memorial Hospital
Genelux Corporation
Tanta University
H. Lee Moffitt Cancer Center and Research Institute
Catalysis SL